The oestrogen-like effect of 4-hydroxytamoxifen on induction of transforming growth factor alpha mRNA in MDA-MB-231 breast cancer cells stably expressing the oestrogen receptor
- PMID: 9667651
- PMCID: PMC2150359
- DOI: 10.1038/bjc.1998.301
The oestrogen-like effect of 4-hydroxytamoxifen on induction of transforming growth factor alpha mRNA in MDA-MB-231 breast cancer cells stably expressing the oestrogen receptor
Abstract
Oestrogens and antioestrogens modulate the synthesis of transforming growth factor alpha (TGF-alpha) in breast cancer cells. The purpose of the present report was to examine regulation of TGF-alpha gene expression by oestradiol (E2) and antioestrogens in MDA-MB-231 breast cancer cells transfected with either the wild-type or mutant oestrogen receptor (ER). We recently reported the concentration-dependent E2 stimulation of TGF-alpha mRNA in MDA-MB-231 ER transfectants (Levenson et al, 1997). We now report that 4-hydroxytamoxifen (4-OHT) shows oestrogen-like effects on the induction of TGF-alpha gene expression in our transfectants. Accumulation of TGF-alpha mRNA in response to both E2 and 4-OHT but not in response to the pure antioestrogen ICI 182,780 suggests that E2-ER and 4-OHT-ER complexes can bind to an oestrogen response element (ERE), located in the promoter region of the TGF-alpha gene and can activate transcription of the gene. Surprisingly, no activation of luciferase expression was observed after transient transfection of the TGF-alpha ERE/luciferase reporter constructs. Possible activation of an alternative ER-mediated pathway responsible for the regulation of TGF-alpha gene expression in the ER transfectants is discussed.
Similar articles
-
Estrogen receptor alpha mediated induction of the transforming growth factor alpha gene by estradiol and 4-hydroxytamoxifen in MDA-MB-231 breast cancer cells.J Steroid Biochem Mol Biol. 2001 Jul;78(1):41-50. doi: 10.1016/s0960-0760(01)00072-3. J Steroid Biochem Mol Biol. 2001. PMID: 11530283
-
Stable transfection of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cells.J Steroid Biochem Mol Biol. 2003 Oct;87(1):47-55. doi: 10.1016/j.jsbmb.2003.07.003. J Steroid Biochem Mol Biol. 2003. PMID: 14630090
-
17 beta-estradiol- and 4-hydroxytamoxifen-induced transactivation in breast, endometrial and liver cancer cells is dependent on ER-subtype, cell and promoter context.J Steroid Biochem Mol Biol. 2003 Jan;84(1):23-31. doi: 10.1016/s0960-0760(03)00010-4. J Steroid Biochem Mol Biol. 2003. PMID: 12648521
-
[The elucidation of the antiestrogen and antitumoral mechanisms of tamoxifen].Bull Cancer. 1994 Jan;81(1):29-37. Bull Cancer. 1994. PMID: 7949581 Review. French.
-
A molecular strategy to control tamoxifen resistant breast cancer.Cancer Surv. 1992;14:55-70. Cancer Surv. 1992. PMID: 1423331 Review.
Cited by
-
The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy.Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3(0 3):245-63. doi: 10.1016/j.mce.2015.06.004. Epub 2015 Jun 5. Mol Cell Endocrinol. 2015. PMID: 26052034 Free PMC article. Review.
-
Flexible small molecular anti-estrogens with N,N-dialkylated-2,5-diethoxy-4-morpholinoaniline scaffold targets multiple estrogen receptor conformations.Cell Cycle. 2017 Aug 3;16(15):1465-1477. doi: 10.1080/15384101.2017.1339848. Epub 2017 Jul 19. Cell Cycle. 2017. PMID: 28723234 Free PMC article.
-
Molecular mechanism of action of bisphenol and bisphenol A mediated by oestrogen receptor alpha in growth and apoptosis of breast cancer cells.Br J Pharmacol. 2013 May;169(1):167-78. doi: 10.1111/bph.12122. Br J Pharmacol. 2013. PMID: 23373633 Free PMC article.
-
Targeted therapy against EGFR and VEGFR using ZD6474 enhances the therapeutic potential of UV-B phototherapy in breast cancer cells.Mol Cancer. 2013 Oct 20;12(1):122. doi: 10.1186/1476-4598-12-122. Mol Cancer. 2013. PMID: 24138843 Free PMC article.
-
Structure-function relationships of the raloxifene-estrogen receptor-alpha complex for regulating transforming growth factor-alpha expression in breast cancer cells.J Biol Chem. 2002 Mar 15;277(11):9189-98. doi: 10.1074/jbc.M108335200. Epub 2001 Dec 20. J Biol Chem. 2002. PMID: 11751902 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous